Multiple sclerosis in north-east Scotland an association with HLA-dow1

Brain

Volumn 110, Issue 1, 1987, Pages 181-196

  Francis, D A ^a,b   Batchelor, J R ^a   Mcdonald, W I ^b   Hing, S N ^a   Dodi, I A ^a   Fielder, A H L ^a   Hern, J E C ^c   Downie, A W ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2;

CENTRAL NERVOUS SYSTEM; DEMYELINATION; DIAGNOSIS; ETIOLOGY; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL;

COMPLEMENT C4; COMPLEMENT C4A; COMPLEMENT C4B; COMPLEMENT FACTOR B; COMPLEMENT SYSTEM PROTEINS; HLA ANTIGENS; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; PHENOTYPE; SCOTLAND;

EID: 0023114458     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/110.1.181     Document Type: Article

References (46)

1. Albert E D, Baur M P, Mayr W R (1984) Nomenclature for factors of the HLA system 1984. In: Histocompatibility Testing 1984. Edited by E. D. Albert, M. P. Baur and W. R. Mayr. Berlin: Springer, pp. 4-8
2. Alper C A, Boenisch T, Watson L (1972) Genetic polymorphism in human glycine-rich beta- glycoprotein. Journal of Experimental Medicine, 135, 68-80
3. Alper C A, Awdeh Z L, Raum D D, Fleischnick E, Yunis E J (1984) Complement genes of the human major histocompatibility complex: implications for linkage disequilibrium and disease associations. In: Immunogenetics. Edited by G. S. Panayi and C. S. David. London: Butterworths, pp. 50-91
4. Batchelor J R (1985) Immunological and genetic aspects of multiple sclerosis. In: Me Alpine's Multiple Sclerosis. Edited by W. B. Matthews. Edinburgh: Churchill Livingstone, pp. 281-300
5. Bertrams J, Grosse-Wilde H, Kuwert E K (1981) Normal distribution of Factor B (Bf) allotypes in multiple sclerosis. Journal of Neuroimmunology 1, 137-140
6. Bodmer W F, Batchelor J R, Bodmer J G, Festenstein H, Morris P J (1978) Nomenclature for factors of the HLA system-1977. In: Histocompatibility Testing 1977. Edited by W. F. Bodmer, J. R. Batchelor, J. G. Bodmer, H. Festenstein and P. J. Morris. Copenhagen: Munksgaard, pp. 14-20
7. B6yum A (1968) Separation of leucocytes from blood and bone marrow: introduction. Scandinavian Journal of Clinical and Laboratory Investigation, 21, Supplement 97-99
8. Brautbar C, Cohen I, Kahana E, Alter M, Jørgensen F, Lamm L (1977) Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis. Tissue Antigens, 10, 291-302
9. Cohen D, Cohen O, Marcadet A, Font M P, Massart C, Hors J, Deschamps I, Dausset J (1984) Association of Class I and Class II MHC restriction fragment polymorphism with HLA-related disease. In: Histocompatibility Testing 1984. Edited by E. D. Albert, M. P. Baur and W. R. Mayr. Berlin: Springer, pp. 557-558
10. Collins R C, Espinoza L R, Plank C R, Ebers G C, Rosenberg R A, Zabriskie J B (1978) A double-blind trial of transfer factor vs placebo in multiple sclerosis patients. Clinical and Experimental Immunology, 33, 1-11
11. Compston A (1981) Multiple sclerosis in the Orkneys. Lancet, 11, 98
12. Compston A (1986) Genetic factors in the aetiology of multiple sclerosis. In: Multiple Sclerosis. Edited by W. I. McDonald and D. H. Silberberg. London: Butterworths, pp. 56-73
13. Compston DAS, Batchelor J R, McDonald W I (1976) B-lymphocyte alloantigens associated with multiple sclerosis. Lancet, II, 1261-1265
14. Compston DAS, Batchelor J R, Earl C J, McDonald W I (1978) Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain, 101, 495-511
15. de Moerloose Ph, Jeannet M, Martins-da-Silva B, Werner-Favre Ch, Rohr J, Gauthier G (1979) Increased frequency of HLA-DRw2 and DRw3 in multiple sclerosis. Tissue Antigens, 13, 357-360
16. Downie A W, Phadke J G (1984) Multiple sclerosis in North East Scotland. Health Bulletin, Edinburgh, 42, 151-156
17. Ebers G C (1983) Genetic factors in multiple sclerosis. Neurologic Clinics, 1, 645-654
18. Fielder A H L, Batchelor J R, Vakarelis B N, Compston DAS, McDonald W I (1981) Optic neuritis and multiple sclerosis: do factor B alleles influence progression of disease? Lancet, 2, 1246-1248
19. Glass D, Raum D, Gibson D, Stillman J S, Schur P H (1976) Inherited deficiency of the second component of complement: rheumatic disease associations. Journal of Clinical Investigation, 58, 853-861
20. Gy6di E, Tauszik T, Petranyi G, KotvAsz A, Pålffy G, Takåcs I, Nemåk P, Hollån S R (1981) The HLA antigen distribution in the Gipsy population in Hungary. Tissue Antigens, 18, 1-12
21. Jersild C, Fog T, Hansen G S, Thomsen M, Svejgaard A, Dupont B (1973) Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet, 2, 1221-1225
22. Kurdi A, Ayesh I, Abdallat A, Maayta U, McDonald W I, Compston DAS, Batchelor J R (1977) Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans. Lancet, 1, 1123-1125
23. ICURTZ KE J F (1961) On the evaluation of disability in multiple sclerosis. Neurology, Minneapolis, 11, 686-694
24. Lachmann P J, Hobart M J (1978a) Complement technology. In: Handbook of Experimental Immunology, Volume 1. Third edition. Edited by D. M. Weir. Oxford: Blackwell, pp. 5A.1-5A.23
25. Lachmann P J, Hobart M J (1978) Complement genetics in relation to HLA. British Medical Bulletin, 34, 247-252
26. McDonald W I (1984) Multiple sclerosis: epidemiology and HLA associations. Annals of the New York Academy of Sciences, 436, 109-117
27. Madigand M, Foger J-F, Fauchet R, Sabouraud O, Genetet B (1982) HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. Journal of the Neurological Sciences, 53, 519-529
28. Mann D L, Abelson L, FIenkart P, Harris S, Amos D B (1975) Serological detection of B lymphocyte antigens. In: Histocompatibility Testing 1975. Edited by F. Kissmeyer-Nielsen. Copenhagen: Munksgaard, pp. 705-707
29. Meo T, Atkinson J, Bernoco M, Bernoco D, Ceppellini R (1976) Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C22 and Bwl5. European Journal of Immunology, 6, 916-919
30. Naito S, Tabira T, Kuroiwa Y (1982) HLA studies of multiple sclerosis in Japan. In: Multiple Sclerosis East and West. Edited by Y. Kuroiwa and L. T. Kurland. Basel and London: Karger, pp. 215-222
31. O’Neill G J, Yang S Y, Dupont B (1978) Two HLA-Wnked loci controlling the fourth component of human complement. Proceedings of the National Academy of Sciences of the USA, 75, 5165-5169
32. Pälffy G (1982) MS in Hungary, including the Gipsy population. In: Multiple Sclerosis, East and West. Edited by Y. Kuroiwa and L. T. Kurland. Basel and London: Karger, pp. 149-157
33. Pandey J P, Goust J-M, Salier J-P, Fudenberg H H (1981) Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. Journal of Clinical Investigation, 67, 1797-1800
34. Poser C M, Paty D W, Scheinberg L, McDonald W I, Davis F A, Ebers G C, Johnson K P, Sibley W A, Silberberg, D H, Tourtellotte W W (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology, 13, 227-231
35. Poskanzer D C, Prenney L B, Sheridan J L, Kondy J Y (1980a) Multiple sclerosis in the Orkney and Shetland Islands. I. Epidemiology, clinical factors, and methodology. Journal of Epidemiology and Community Health, 34, 229-239
36. Poskanzer D C, Terasaki P I, Prenney L B, Sheridan J L, Park M S (1986) Multiple sclerosis in the Orkney and Shetland Islands. III. Histocompatibility determinants. Journal of Epidemiology and Community Health, 34, 253-257
37. Propert D N, Bernard CCA, Simons M J (1982) Gm allotypes and multiple sclerosis. Journal of Immunogenetics, 9, 359-361
38. Raun N E, Fog T, Heltberg A, Platz P (1980) Correlation of the course of MS and histocompatibility antigens. In: Progress in Multiple Sclerosis Research. Edited by H. J. Bauer, S. Poser and G. Ritter. Berlin: Springer, pp. 456-459
39. Schröder R, Zander H, Andreas A, Mauff G (1983) Multiple sclerosis: immunogenetic analysis of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6 and GLO polymorphisms. Immunobiology, 164, 160-170
40. Shepherd D I, Downie A W (1978) Prevalence of multiple sclerosis in north-east Scotland. British Medical Journal, 2, 314-316
41. Stendahl-Brodin L, Link H, Möller E, Norrby E (1979) Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurologica Scandinavica, 59, 297-308
42. Stewart G J, Basten A, Kirk R L (1979) Strong linkage disequilibrium between HLA-Dw2 and Bf S in multiple sclerosis and in the normal population. Tissue Antigens, 14, 86-97
43. Stewart G J, McLeod J G, Basten A, Bashir H V (1981) HLA family studies and multiple sclerosis: a common gene, dominantly expressed. Human Immunology, 3, 13-29
44. Stewart G J, Kirk R L (1983) The genetics of multiple sclerosis: the HLA system and other genetic markers. In: Multiple Sclerosis: Pathology, Diagnosis and Management. Edited by J. F. Hallpike, C. W. M. Adams and W. W. Tourtellotte. London: Chapman and Hall, pp. 97-128
45. Terasaki PI (1980) Nomenclature for factors of the HLA system 1980. In: Histocompatibility Testing 1980. Edited by P. I. Terasaki. Los Angeles: UCLA Tissue Typing Laboratory, pp. 18-20
46. Terasaki P I, Mickey M R (1976) A single mutation hypothesis for multiple sclerosis based on the HL-A system. Neurology, Minneapolis, 26, Supplement, 56-58